Antibacterial and toxicity evaluation of C-phycocyanin and cell extract of filamentous freshwater cyanobacterium Westiellopsis sps

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 2, 2008, Pages 79-82

  Sabarinathan, K G ^a   Ganesan, G ^b  

^a Covalence Inc ^*  (United States)

^b TAMIL NADU AGRICULTURAL UNIVERSITY   (India)

Author keywords

Antibacterial; Cyanobacteria; Phycocyanin; Toxicity

Indexed keywords

C PHYCOCYANIN; CELL EXTRACT; FRESH WATER; PHYCOBILIPROTEIN; WESTIELLOPSIS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOASSAY; BODY WEIGHT; CONTROLLED STUDY; CYANOBACTERIUM; DRUG ISOLATION; GROWTH INHIBITION; NONHUMAN; PSEUDOMONAS; SILKWORM; WESTIELLOPSIS; XANTHOMONAS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BOMBYX; CELL EXTRACTS; CYANOBACTERIA; MICROBIAL SENSITIVITY TESTS; PHYCOCYANIN; PSEUDOMONAS; TOXICITY TESTS; XANTHOMONAS;

EID: 45449086134     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. CARMICHAEL WW. Cyanobacteria secondary metabolites: The cyanotoxins. J Appl Bacteriol 1992; 72: 445-459.
2. FALCH BS, KONIG GM, WRIGHT AD, STICHER O, ANGERHOFER CK, PEZZUTO JM, BACHMANN H. Biological activities of cyanobacteria: Evaluation of extracts and pure compounds. Planta Med 1995; 61:321-328.
3. MOORE RE. Cyclic peptides and depsipeptides from cyanobacteria: A review. J Ind Microbiol 1996; 16: 134-143.
4. NAMIKOSHI M, RINEHART KL. Bioactive compounds produced by cyanobacteria. J Ind Microbiol 1996; 17: 373-384.
5. SOLTANI, KHAVARI-NEJAD, TABATABAEI YAZDI, SHOKRAVI, FERNANDEZ-VALIENTE. Screening of Soil Cyanobacteria for antifungal and antibacterial activity. Pharm Biol 2005; 43: 455-459.
6. RIPPKA R, DERUELLES J, WATERBURY JB, HERDMAN M, STANIER RY. Generic assignments, strain histories, and properties of pure cultures of cyanobacteria. J Gen Microbiol 1979; 111:1-61.
7. DESIKACHARY TV. Cyanophyta. In: Indian Council of Agricultural Research monographs, New Delhi. New York, Academic Press. 1959; p. 686.
8. SHIBIB BA, KHAN LA, RAHMAN R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 1993; 292:267-270.
9. BOUSSIBA S, RICHMOND A. Isolation and purification of phycocyanins from the blue green alga Spirulina platensis. Arch Microbiol 1979; 120: 155-159.
10. BENNET J, BOGORAD L. Complementary chromate adaptation in a filamentous blue gree alga. J Cell Biol 1973; 58: 419-435.
11. COLLINS CH, LYNE PM, GRANGE JM. Antimicrobial sensitivity and assay tests. In: Collins CH, Lyne PM & Grange JM (Ed), Collins and Lyne's Microbiological Methods. 1989; 8th edn. Butterworths, London.
12. BELAY A, OTA Y, MIYAKAWA K, SHIMAMATSU H. Current knowledge on potential health benefits of Spirulina. J Appl Phycol 1993; 5: 235-241.
13. BLOOR S, ENGLAND RR. Elucidation and optimization of the medium constituents controlling antibiotic production by the cyanobacterium Nostoc muscorum. Enzym Microbiol Technol 1991; 13: 76-81.
14. KREITLOW S, MUNDT S, LINDEQUIST U. Cyanobacteria-a potential source of new biologically active substances. J Biotech 1999; 70: 61-63.
15. ISSA AA. Antibiotic production by the Cyanobacteria Oscillatoria angustissima and Calothrix parietina. Environ Toxicol Pharm 1999; 8: 33-37.
16. TYAGI MB, THAKUR JK, SINGH DP, KUMAR A, PRASUNA EG, KUMAR A. Cyanobacterial toxins: The current status. J Microbiol Biotechnol 1999; 9: 9-21.
17. SINGH S, KATE BN, BANERJEE UC. Bioactive compounds from cyanobacteria and microalgae: An overview. Crit Rev Biotechnol 2005; 25: 73-95.